Lava Therapeutics Nv earnings were -$31.5M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest LVTX earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$3.8M, down 8.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, LVTX reported annual earnings of -$26.2M, with -43.8% growth.
Lava Therapeutics Nv Earnings Reports & History FAQ
What were Lava Therapeutics Nv's earnings last quarter?
On LVTX's earnings call on Invalid Date, Lava Therapeutics Nv (NASDAQ: LVTX) reported Q1 2025 earnings per share (EPS) of -$0.14, up 540.91% year over year. Total LVTX earnings for the quarter were -$3.78 million. In the same quarter last year, Lava Therapeutics Nv's earnings per share (EPS) was -$0.02.
Is Lava Therapeutics Nv profitable or losing money?
As of the last Lava Therapeutics Nv earnings report, Lava Therapeutics Nv is currently losing money. Lava Therapeutics Nv's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$30.48 million, a 1.74% decrease year over year.
What was LVTX's earnings growth in the past year?
As of Lava Therapeutics Nv's earnings date in Invalid Date, Lava Therapeutics Nv's earnings has grown year over year. LVTX earnings in the past year totalled -$31.51 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.